Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of AKTX will rise by +1.12% over the next 2 Weeks and hit $9.40 by Tuesday, August 4, 2026. In that time frame, AKTX's share price is expected to range between $7.32 and $11.60.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 4, 2026 | 7.32 | 9.40 | 11.60 |
| Aug 3, 2026 | 6.66 | 8.78 | 10.94 |
| Jul 31, 2026 | 7.66 | 9.75 | 11.88 |
| Jul 30, 2026 | 6.73 | 8.95 | 10.92 |
| Jul 29, 2026 | 7.21 | 9.33 | 11.51 |
| Jul 28, 2026 | 7.89 | 9.85 | 12.10 |
| Jul 27, 2026 | 7.10 | 9.24 | 11.20 |
| Jul 24, 2026 | 8.10 | 10.20 | 12.32 |
| Jul 23, 2026 | 7.38 | 9.40 | 11.49 |
| Jul 22, 2026 | 7.77 | 9.79 | 11.94 |
AKTX shares fell -12.80% in Tuesday, July 21, 2026's trading session, dropping from a previous close of $10.66 to move at $9.30. The stock demonstrated notable intraday movement (see AKTX's key stats for a full breakdown), fluctuating between $9.05 and $12.30, a +35.99% trading range. While recent weeks have seen some volatility, AKTX has managed to secure a -34.59% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 70.01K shares changing hands, 16.03K more than the previous session. This amounted to $650.75K in total market activity.
Will AKTX Continue Its Upward Trend?
According to analyst ratings and projections for AKTX, Akari Therapeutics, Plc shares are anticipated to increase by +19.88%, potentially reaching $11.60 per share by August 4, 2026. Short-term technical indicators currently suggest a neutral sentiment for AKTX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the AKTX stock forecast, now is a good time to buy AKTX stock because its current trading price is -1.11% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on AKTX covering social and institutional perspectives.
AKTX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into AKTX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 32.73% to 44.18%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 47.92%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.40%, maintains a neutral outlook for the long term. Insights into AKTX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Akari Therapeutics Short-Term Forecasts
AKTX Forecast For Next 5 Days
Our algorithm anticipates Akari Therapeutics (AKTX) stock could hit $0.00 by Jul 29, 2026. This represents a - fall from today's price, following a -4.04% change over the past five days.
AKTX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Akari Therapeutics, Plc (AKTX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $2.76, which would mean a -70.31% decrease from the current price of $9.30. Projections for this period range from a high of $20.18 to a low of $0.00.
AKTX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Akari Therapeutics's price over the next three months point to a drop. AKTX stock is expected to peak at $12.18 on Jul 31, 2026 before potentially dipping to $2.11 on Oct 19, 2026. On average, AKTX is likely to trade around $7.24 in the coming 90 days.
Akari Therapeutics Stock Forecast 2025
Based on our predictive models, Akari Therapeutics (AKTX) is expected to trade between $0.00 and $12.18 throughout 2026. This would result in an average price of $6.27, potentially offering investors a -32.54% return from current levels.
Akari Therapeutics, Plc Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, Akari Therapeutics, Plc (AKTX) is positioned to show a strong performance in July 2026. The price is predicted to move between $5.76 and $12.18, settling at an average of $9.31. This could translate to a +0.16% gain.
August 2026
Based on current market signals, Akari Therapeutics, Plc is projected to trend august 2026. We forecast a trading range from $3.13 to $11.51, with a likely average price of $7.34. Investors could expect a potential return of -21.03%.
September 2026
Our predictive algorithms indicate Akari Therapeutics, Plc stock may see a shift in September 2026. The expected range spans $3.35–$10.86, with an average target of $7.42. This represents a cautious outlook and a possible loss of -20.17%.
October 2026
Analyzing established trends, Akari Therapeutics, Plc looks set to move in October 2026. Projections place the stock between $1.38 and $9.44, averaging around $5.55. This suggests a -40.29% loss from current levels.
November 2026
Market indicators suggest Akari Therapeutics, Plc could experience notable changes during November 2026. Prices could fluctuate within $1.20 to $8.63, with a midpoint forecast of $5.51. The stock might deliver a -40.72% loss.
December 2026
Forecasting for December 2026, models estimate that Akari Therapeutics, Plc may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $7.81, averaging $4.52. This signals a cautious trajectory with potential returns around -51.37%.
January 2027
According to our latest forecast models, Akari Therapeutics, Plc (AKTX) is positioned to show a strong performance in January 2027. The price is predicted to move between $0.00 and $5.51, settling at an average of $3.11. This could translate to a -66.54% loss.
February 2027
Based on current market signals, Akari Therapeutics, Plc is projected to trend february 2027. We forecast a trading range from $0.00 to $4.45, with a likely average price of $2.95. Investors could expect a potential return of -68.26%.
March 2027
Our predictive algorithms indicate Akari Therapeutics, Plc stock may see a shift in March 2027. The expected range spans $0.00–$3.62, with an average target of $1.84. This represents a cautious outlook and a possible loss of -80.20%.
April 2027
Analyzing established trends, Akari Therapeutics, Plc looks set to move in April 2027. Projections place the stock between $0.00 and $2.33, averaging around $1.73. This suggests a -81.39% loss from current levels.
May 2027
Market indicators suggest Akari Therapeutics, Plc could experience notable changes during May 2027. Prices could fluctuate within $0.00 to $0.00, with a midpoint forecast of $1.68. The stock might deliver a -81.93% loss.
June 2027
Forecasting for June 2027, models estimate that Akari Therapeutics, Plc may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $1.44. This signals a cautious trajectory with potential returns around -84.51%.
July 2027
According to our latest forecast models, Akari Therapeutics, Plc (AKTX) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.00 and $0.00, settling at an average of $1.65. This could translate to a -82.25% loss.
AKTX's history of dividends and stock splits also plays a role in long-term investor confidence.

